Do you want to join a workplace that inspires innovation and fosters work/life balance? We have multiple open positions, check them out: lnkd.in/gxr4T7X #hiring #Vancouverjobs #openposition

You can also find us at Life Sciences BC job board #lifesciencejobs #BCjobs lifesciencesbc.ca/jobs/

If you or someone you know like to join a workplace that inspires innovation & fosters work/life balance, we have multiple open positions at Eupraxia! #hiring #BCJobs #VancouverJobs #Analytical #ProcessDevelopment #Formulation #QA #Accountant lnkd.in/gxr4T7X

Eupraxia Pharma has multiple job openings, including some requiring material characterization techniques. If you're interested, you should check them out!

Eupraxia team took part in a 5k run this morning at #CIBCRunfortheCure in two cities, with the hope for A Future Without Breast Cancer! #teambuilding

Presenting companies include: Agilik, Augurex Eupraxia Pharma GenomeMe Labs Inc. @ThromboLUX MedGenesis Therapeutix, Naegis Pharmaceuticals NZ Technologies Inc. Pacylex Pharmaceuticals, Primary Peptides & Qu Biologics Inc. Tickets: bit.ly/2nKGGsI #LSBCinvest Lumira Ventures @C_D_R_D

Our CEO, Dr Helliwell presented our lead product at #Lsbcevents Investor Summit by Life Sciences BC, @C_D_R_D, TRIUMF Innovations & BIOTECanada , where in a panel Navdeep Bains ISED discussed Health/Biosci Economic Strategy Table Report

Eupraxia team (Samuel Mercer and Sarah Luettgen) is excited to attend #BIOEurope in Copenhagen from Nov. 4-8. We will be exploring #partnering opportunities for our lead product in knee #osteoarthritis, and pipeline assets in post-operative pain and infection.

Thanks to all organizers and extraordinary participants. Eupraxia team (Samuel Mercer and Sarah Luettgen) in beautiful Copenhagen at #BIOEurope

We are honored to see our CSO, Dr. Amanda Malone featured in #womeninSTEM for April by @WomeninSciUVic. Read her interview, if you are interested to know what message she has for young scientists:

Eupraxia Pharmaceuticals Inc. Provides Corporate Update and Reports First Quarter 2021 Financial Results prn.to/2Rbqeo3

Eupraxia to Present at the Raymond James Human Health Innovations Conference prn.to/3iMbJlP

Eupraxia's Research and Development team is hiring! lifesciencesbc.ca/job/research-s…

Eupraxia Pharmaceuticals Inc. Announces Authorization of Clinical Trial Application for Phase 2 Trial of EP-104IAR... prn.to/3ivzwoc "Authorization of our CTA in Denmark is an important step for the Company and EP-104IAR," said Dr. James Helliwell, CEO of Eupraxia

Eupraxia is looking for qualified candidates to join our Finance and QA & Regulatory teams. Check them out! lifesciencesbc.ca/job/accountant/ lifesciencesbc.ca/job/qa-regulat…

Eupraxia Pharmaceuticals Inc. Provides Update for Phase 2 Osteoarthritis Drug Candidate EP-104IAR prn.to/3nYBiTd

Eupraxia Pharmaceuticals Inc. Commences Patient Screening For Its Phase 2 Trial For Osteoarthritis Drug Candidate ... prn.to/3lR5PzF

Eupraxia is growing and we're looking for qualified candidates to join our team. We're currently looking for an Analytical Chemistry Manager. Check out our website for details around this opportunity. eupraxiapharma.com/careers/job-de…

Our CEO James Helliwell will be presenting tomorrow, Wednesday November 3rd at 3pm at the Invest in BC conference. Register at the link below! accelevents.com/e/investinbc?a…

Eupraxia will be presenting at the H.C. Wainwright BIOCONNECT Virtual Conference! Our on-demand presentation will be available starting on Monday, January 10, 2022, at 7:00 AM ET and can be found here; journey.ct.events/view/68858e45-…